Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a minor content/metadata update and does not change any study details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous version v3.6.2. This appears to be a minor maintenance update that does not modify the study content or patient-facing information.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag on the page was updated to v3.6.2, replacing the previous v3.6.0. This indicates an update to the study documents or protocol associated with the clinical trial record.SummaryDifference0.1%

- Check54 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); an existing header style for Intervention/Treatment was updated, while the old Revision: v3.5.5 was removed and Revision: v3.6.0 was added.SummaryDifference0.4%

- Check61 days agoChange DetectedThe page now displays a new Revision: v3.5.5 tag, replacing Revision: v3.5.4, indicating a minor internal update to the site's versioning rather than a change to study details.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small platform update and does not alter the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.